KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Change in Cash: 2017-2025

Historic Change in Cash for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to -$34.0 million.

  • Elanco Animal Health's Change in Cash fell 145.95% to -$34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year decrease of 87.60%. This contributed to the annual value of $116.0 million for FY2024, which is 1557.14% up from last year.
  • Elanco Animal Health's Change in Cash amounted to -$34.0 million in Q3 2025, which was down 165.38% from $52.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Change in Cash registered a high of $185.0 million during Q4 2021, and its lowest value of -$296.0 million during Q1 2022.
  • Over the past 3 years, Elanco Animal Health's median Change in Cash value was $2.0 million (recorded in 2023), while the average stood at $14.5 million.
  • In the last 5 years, Elanco Animal Health's Change in Cash plummeted by 3,388.89% in 2022 and then spiked by 3,600.00% in 2024.
  • Quarterly analysis of 5 years shows Elanco Animal Health's Change in Cash stood at $185.0 million in 2021, then slumped by 162.16% to -$115.0 million in 2022, then soared by 85.22% to -$17.0 million in 2023, then dropped by 29.41% to -$22.0 million in 2024, then plummeted by 145.95% to -$34.0 million in 2025.
  • Its Change in Cash was -$34.0 million in Q3 2025, compared to $52.0 million in Q2 2025 and $19.0 million in Q1 2025.